Long term efficacy and safety in children and young adults with treatment resistant epilepsy treated with Cannabidiol

Trial Profile

Long term efficacy and safety in children and young adults with treatment resistant epilepsy treated with Cannabidiol

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 03 Jan 2018

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions; Expanded access; Therapeutic Use
  • Most Recent Events

    • 03 Jan 2018 New trial record
    • 05 Dec 2017 Results presented at the 71st Annual Meeting of the American Epilepsy Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top